Influenza Pandemic: Lessons Learned from the H1N1 Pandemic Should Be Incorporated into Future Planning

Effect of Food and Beverage Prices on Children’s Weights

by Bernice Steinhardt and Marcia Crosse
Paperback, 67 pages, 2011, $25.00
ISBN: 9781437988318

The 2009 H1N1 influenza pandemic was the first human pandemic in over four decades; the CDC estimates that there were 89 million U.S. cases. Over $6 billion was available for the response, led by the Departments of Health and Human Services (HHS) and Homeland Security, with coordination provide by the Homeland Security Council through its National Security Staff.

In particular, CDC worked with states and localities to communicate with the public and to distribute H1N1 vaccine and supplies. This report examines: (1) how CDC used the funding; (2) the key issues raised by the federal response; and (3) the actions taken to identify and incorporate lessons learned. Charts and tables. This is a print on demand report.

Purchase this print-on-demand publication for $25.00:

New Government Report: New Jersey Syringe Access Program Demonstration Project Interim Report: Implementation of P.L. 23006, c.99, Blood-borne Disease Harm Reduction Act

New Jersey Syringe Access Program Demonstration Project Interim Report: Implementation of P.L. 23006, c.99, Blood-borne Disease Harm Reduction Act
by Laurence E. Ganges
Paperback, 17 pages, 2010, ISBN: 9781437935059, $15.00

Four years ago, New Jersey became the last state to approve needle-exchange programs to curb the spread of HIV/AIDS by drug addicts, reports the Philadelphia Inquirer. A new state Health Department report shows those efforts are making a difference, and offers evidence that the pilot programs should continue. But they are threatened by a lack of funding.

Injection drug use is one of the most common methods of transmission for a number of preventable life‐threatening diseases, including HIV and Hepatitis C.

Along with drug treatment and behavioral health interventions, syringe access programs are an important component in attempting to prevent/reduce the risks associated with injection drug use.

On Dec. 19, 2006, Governor Corzine signed the “Blood‐borne Disease Harm Reduction Act,” which allows a maximum of six municipalities in NJ to establish a demonstration syringe access program.

This report presents an evaluation of the Demonstration Project based on data collected from the inception of the first site from Nov. 27, 2007 through Dec. 31, 2009. Charts and tables.

Purchase this print-on-demand publication for $15.00: